Etanercept attenuates TNFα-mediated kidney injury in a rat model of brain death kidney donation.

Authors

T Pinto Coelho, J Abdelmalki, M Navez, M Vandermeulen, P Erpicum, O Detry, F Jouret

Published in

American journal of physiology. Renal physiology. Jun 27, 2026. Epub Jun 27, 2026.

Abstract

Brain death (BD) induces a robust inflammatory response that impairs kidney quality before transplantation. Given that TNFα is a central upstream mediator of BD-related injury, we investigated whether selective TNFα inhibition using etanercept could mitigate renal damage in a rat model of BD. BD was maintained for 6 hours in anesthetized rats (n=6 controls; n=12 etanercept-treated; balanced for sex), after which animals were randomized to receive either etanercept (ETNCPT) or vehicle (CTL). We evaluated serum biomarkers, histological kidney injury, immune cell infiltration, and whole-kidney transcriptomic profiles. Etanercept significantly reduced circulating TNFα levels (15.25[12.30-21.05] vs. 34.23[26.03-50.19] pg/mL; p<0.001), while other cytokines remained unchanged. Kidney function parameters (serum creatinine, BUN), electrolytes, and hemodynamics were similar accross groups. In contrast, etanercept markedly attenuated renal injury, reducing acute tubular necrosis (30.0 [15.0-35.0]% vs. 42.5 [40.0-51.3]%; p<0.001), CD11b⁺ myeloid infiltration (0.13 [0.11-0.15]% vs. 0.21 [0.19-0.27]%; p<0.001), tubular KIM-1 expression (0.04 [0.01-0.08]% vs. 0.17 [0.13-0.18]%; p<0.001), and apoptosis (-69%; p=0.036). Transcriptomic analysis identified 281 differentially expressed genes after TNFα blockade, with strong inhibition of inflammatory and apoptotic pathways including TNF signaling, TNFR1/TNFR2 activation, death receptor signaling, and cytokine storm signaling. Predicted downstream effects included reduced kidney cell death and inflammation. Sex-stratified analyses showed similar directional effects in males and females. In summary, early TNFα blockade after BD selectively neutralizes TNFα, limits immune recruitment, and suppresses injury and inflammatory signaling at cellular and transcriptomic levels. Targeting TNFα during kidney donor management may offer a promising strategy to improve kidney quality before transplantation.

PMID:
42363823
Bibliographic data and abstract were imported from PubMed on 27 Jun 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.